Gene · 4102
Papers3,353
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 3,353
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| EHMT2/G9a as an Epigenetic Target in Pediatric and Adult Brain Tumors. | Int J Mol Sci | 2021 | 34681949 | PubTator, text mining | PubMed |
| Integration of Epigenetic Mechanisms into Non-Genotoxic Carcinogenicity Hazard Assessment: Focus on DNA Methylation and Histone Modifications. | Int J Mol Sci | 2021 | 34681626 | PubTator, text mining | PubMed |
| Vaccines for Non-Viral Cancer Prevention. | Int J Mol Sci | 2021 | 34681560 | PubTator, text mining | PubMed |
| Implications of Antigen Selection on T Cell-Based Immunotherapy. | Pharmaceuticals (Basel) | 2021 | 34681217 | PubTator, text mining | PubMed |
| Landscape of Immune-Related Markers and Potential Therapeutic Targets in Soft Tissue Sarcoma. | Cancers (Basel) | 2021 | 34680396 | PubTator, text mining | PubMed |
| Overcoming Resistance to Immunotherapy in Advanced Cutaneous Squamous Cell Carcinoma. | Cancers (Basel) | 2021 | 34680282 | PubTator, text mining | PubMed |
| Trial watch: intratumoral immunotherapy. | Oncoimmunology | 2021 | 34676147 | PubTator, text mining | PubMed |
| CALR-TLR4 Complex Inhibits Non-Small Cell Lung Cancer Progression by Regulating the Migration and Maturation of Dendritic Cells. | Front Oncol | 2021 | 34660305 | PubTator, text mining | PubMed |
| Advances in Adoptive Cell Therapy Using Induced Pluripotent Stem Cell-Derived T Cells. | Front Immunol | 2021 | 34650571 | PubTator, text mining | PubMed |
| The Role of Long Non-Coding RNA and microRNA Networks in Hepatocellular Carcinoma and Its Tumor Microenvironment. | Int J Mol Sci | 2021 | 34638971 | PubTator, text mining | PubMed |
| At the Cutting Edge against Cancer: A Perspective on Immunoproteasome and Immune Checkpoints Modulation as a Potential Therapeutic Intervention. | Cancers (Basel) | 2021 | 34638337 | PubTator, text mining | PubMed |
| Management of Resectable Stage III-N2 Non-Small-Cell Lung Cancer (NSCLC) in the Age of Immunotherapy. | Cancers (Basel) | 2021 | 34638296 | PubTator, text mining | PubMed |
| Keeping Myeloma in Check: The Past, Present and Future of Immunotherapy in Multiple Myeloma. | Cancers (Basel) | 2021 | 34638271 | PubTator, text mining | PubMed |
| Recent Advances in Experimental Dendritic Cell Vaccines for Cancer. | Front Oncol | 2021 | 34631558 | PubTator, text mining | PubMed |
| Multipeptide stimulated PBMCs generate TEM/TCM for adoptive cell therapy in multiple myeloma. | Oncotarget | 2021 | 34611479 | PubTator, text mining | PubMed |
| Gestational Exposure to Ultrafine Particles Reveals Sex- and Dose-Specific Changes in Offspring Birth Outcomes, Placental Morphology, and Gene Networks. | Toxicol Sci | 2021 | 34609516 | PubTator, text mining | PubMed |
| Tumor-Infiltrating PD-1hiCD8+-T-Cell Signature as an Effective Biomarker for Immune Checkpoint Inhibitor Therapy Response Across Multiple Cancers. | Front Oncol | 2021 | 34604032 | PubTator, text mining | PubMed |
| A Machine Learning Model to Predict the Triple Negative Breast Cancer Immune Subtype. | Front Immunol | 2021 | 34603338 | PubTator, text mining | PubMed |
| Multicenter, double-blind, placebo-controlled trial of seviprotimut-L polyvalent melanoma vaccine in patients with post-resection melanoma at high risk of recurrence. | J Immunother Cancer | 2021 | 34599031 | PubTator, text mining | PubMed |
| Combination strategies to maximize the benefits of cancer immunotherapy. | J Hematol Oncol | 2021 | 34579759 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4102/papers?page=37